These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29320955)

  • 1. Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence.
    Zeybek B; Costantine M; Kilic GS; Borahay MA
    Reprod Sci; 2018 Jun; 25(6):802-817. PubMed ID: 29320955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evidence of statin therapy in non-dyslipidemic disorders.
    Ferri N; Corsini A
    Pharmacol Res; 2014 Oct; 88():20-30. PubMed ID: 24548821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins: perspectives in cancer therapeutics.
    Corcos L; Le Jossic-Corcos C
    Dig Liver Dis; 2013 Oct; 45(10):795-802. PubMed ID: 23490341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins in the treatment of polycystic ovary syndrome.
    Kodaman PH; Duleba AJ
    Semin Reprod Med; 2008 Jan; 26(1):127-38. PubMed ID: 18181091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and protein prenylation in cancer cell biology and therapy.
    Garcia-Ruiz C; Morales A; Fernandez-Checa JC
    Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel prospects of statins as therapeutic agents in cancer.
    Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
    Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins induce differentiation and cell death in neurons and astroglia.
    März P; Otten U; Miserez AR
    Glia; 2007 Jan; 55(1):1-12. PubMed ID: 16998865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mevalonate Pathway and Human Cancers.
    Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
    Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Mevalonate Pathway for Treating Esophageal Cancer.
    Wong JVS; Fatehi Hassanabad A
    J Gastrointest Cancer; 2021 Jun; 52(2):819-821. PubMed ID: 33931828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
    Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
    Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
    Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
    Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
    Ermini L; Post M; Caniggia I
    Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
    Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
    Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
    Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
    Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.